BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1722410)

  • 1. Enhancement of etoposide and methotrexate sensitivity by indomethacin in vitro.
    Maca RD
    Anticancer Drug Des; 1991 Nov; 6(5):453-66. PubMed ID: 1722410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the growth of Lewis lung carcinoma by indomethacin in conventional, nude, and beige mice.
    Maca RD
    J Biol Response Mod; 1988 Dec; 7(6):568-80. PubMed ID: 3216222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipyridamole enhancement of etoposide sensitivity.
    Howell SB; Hom DK; Sanga R; Vick JS; Chan TC
    Cancer Res; 1989 Aug; 49(15):4147-53. PubMed ID: 2545335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of cell proliferation and BCR-ABL phosphorylation in acute lymphoblastic leukemia cells expressing Mr 190,000 BCR-ABL protein by a tyrosine kinase inhibitor (CGP-57148).
    Beran M; Cao X; Estrov Z; Jeha S; Jin G; O'Brien S; Talpaz M; Arlinghaus RB; Lydon NB; Kantarjian H
    Clin Cancer Res; 1998 Jul; 4(7):1661-72. PubMed ID: 9676840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro cytotoxicity of VP-16-213 and nitrogen mustard: agonistic on tumor cells but not on normal human bone marrow progenitors.
    Lemoli RM; Gulati SC
    Exp Hematol; 1990 Oct; 18(9):1008-12. PubMed ID: 2397748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sorafenib induces apoptosis specifically in cells expressing BCR/ABL by inhibiting its kinase activity to activate the intrinsic mitochondrial pathway.
    Kurosu T; Ohki M; Wu N; Kagechika H; Miura O
    Cancer Res; 2009 May; 69(9):3927-36. PubMed ID: 19366808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of a functional prostaglandin E2-protein kinase A coupling with responsiveness of metastatic Lewis lung carcinoma variants to prostaglandin E2 and to prostaglandin E2-producing nonmetastatic Lewis lung carcinoma variants.
    Young MR; Duffie GP; Lozano Y; Young ME; Wright MA
    Cancer Res; 1990 May; 50(10):2973-8. PubMed ID: 2159367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and properties of an etoposide-resistant human leukaemic CCRF-CEM cell line.
    Patel S; Austin CA; Fisher LM
    Anticancer Drug Des; 1990 Feb; 5(1):149-57. PubMed ID: 2156515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verapamil-induced augmentation of etoposide accumulation in L1210 cells in vitro.
    Yalowich JC; Ross WE
    Cancer Res; 1985 Apr; 45(4):1651-6. PubMed ID: 3978633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of etoposide resistance in non-P-glycoprotein expressing multidrug resistant tumor cell lines by novobiocin.
    Rappa G; Lorico A; Sartorelli AC
    Cancer Res; 1993 Nov; 53(22):5487-93. PubMed ID: 8106148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of differential drug uptake, efflux, and binding of etoposide in sensitive and resistant human tumor cell lines: implications for the mechanisms of drug resistance.
    Politi PM; Sinha BK
    Mol Pharmacol; 1989 Mar; 35(3):271-8. PubMed ID: 2564628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of prostaglandin E2-producing nonmetastatic Lewis lung carcinoma cells on the migration of prostaglandin E2-responsive metastatic Lewis lung carcinoma cells.
    Young MR; Young ME; Wepsic HT
    Cancer Res; 1987 Jul; 47(14):3679-83. PubMed ID: 3109729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity.
    Zingarelli B; Southan GJ; Gilad E; O'Connor M; Salzman AL; Szabó C
    Br J Pharmacol; 1997 Feb; 120(3):357-66. PubMed ID: 9031736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etoposide-induced cytotoxicity in two human T-cell leukemic lines: delayed loss of membrane permeability rather than DNA fragmentation as an indicator of programmed cell death.
    Catchpoole DR; Stewart BW
    Cancer Res; 1993 Sep; 53(18):4287-96. PubMed ID: 8364925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and growth inhibition studies of methotrexate and aminopterin analogues containing a tetrazole ring in place of the gamma-carboxyl group.
    McGuire JJ; Russell CA; Bolanowska WE; Freitag CM; Jones CS; Kalman TI
    Cancer Res; 1990 Mar; 50(6):1726-31. PubMed ID: 2306727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandins and prostaglandin synthetase inhibitors regulate the synthesis of complement components by human monocytes.
    Lappin DF; Whaley K
    Clin Exp Immunol; 1982 Sep; 49(3):623-30. PubMed ID: 6816495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What regulates placental steroidogenesis in 90-day pregnant ewes?
    Weems YS; Kim L; Tsuda V; Yin C; Weems CW
    Prostaglandins Other Lipid Mediat; 2007 Aug; 84(1-2):54-65. PubMed ID: 17643888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of etoposide (VP-16) cytotoxicity by verapamil or cyclosporine in multidrug-resistant human leukemic cell lines and normal bone marrow.
    Chao NJ; Aihara M; Blume KG; Sikic BI
    Exp Hematol; 1990 Dec; 18(11):1193-8. PubMed ID: 2226679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined modalities of resistance in etoposide-resistant human KB cell lines.
    Ferguson PJ; Fisher MH; Stephenson J; Li DH; Zhou BS; Cheng YC
    Cancer Res; 1988 Nov; 48(21):5956-64. PubMed ID: 2844393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of Lewis lung carcinoma cell migration by prostaglandin E2 produced by macrophages.
    Young MR; Newby M
    Cancer Res; 1986 Jan; 46(1):160-4. PubMed ID: 3455665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.